Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The RNA- and DNA-Binding Protein Y-Box Binding Protein 1 (YB-1) Regulates iNKT Cell Development.

European journal of immunology·2026
Same author

Preclinical evaluation of a novel CD4 specific CAR NK cell therapy for T-cell malignancies.

Cytotherapy·2026
Same author

Src-family kinase control of CAR signaling: the paradoxical and multifaceted role of LCK.

Immunology letters·2026
Same author

Anti-CD4 antibody-modulated transplants for GVHD prevention in hematopoietic cell transplantation.

Blood·2026
Same author

"Live" cell shipment-a forward-looking transport option for cryo-sensitive cell-based therapies.

Frontiers in bioengineering and biotechnology·2025
Same author

Editorial: Exploring lymphocyte signaling: from health to disease.

Frontiers in immunology·2025
Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026
Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026
Same journal

Complement in Traumatic Brain Injury: Linking Acute Injury to Chronic Neurodegeneration.

European journal of immunology·2026
Same journal

Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles.

European journal of immunology·2026
Same journal

The Memory Inflation Response Against Spread-Defective CMV Requires Priming-Independent CD4<sup>+</sup> T Cell Help.

European journal of immunology·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

Methodological Insights Into T-Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation.

Nekruz Abdulhaqov1,2, Lady Tatiana Albarracin Melo1, Ines Meinert1

  • 1Medical Faculty, Institute for Clinical Immunology and Cell Therapeutics, Otto-von-Guericke University, Magdeburg, Germany.

European Journal of Immunology
|June 17, 2026
PubMed
Summary
This summary is machine-generated.

Pharmacological (PMA/ionomycin) and receptor-mediated (CD3/CD28) T-cell activation trigger distinct signaling pathways. CD3/CD28 activates ERK and IL-2/STAT5, while PMA/ionomycin primarily drives ERK-dependent proliferation.

More Related Videos

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

Related Experiment Videos

Last Updated: Jun 18, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

Area of Science:

  • Immunology
  • Cellular Signaling
  • Molecular Biology

Background:

  • T-cell activation is crucial for adaptive immunity.
  • Distinct stimuli can elicit different cellular responses.
  • Understanding T-cell activation pathways informs therapeutic strategies.

Purpose of the Study:

  • To compare the distinct signaling programs induced by pharmacological (PMA/ionomycin) and receptor-mediated (CD3/CD28) stimulation in primary human T cells.
  • To elucidate the mechanistic differences in T-cell responses to these activation methods.

Main Methods:

  • Primary human T cells were stimulated using PMA/ionomycin and CD3/CD28 antibodies.
  • Signaling pathway activation (ERK, IL-2/STAT5) and cellular responses (proliferation, CD25 upregulation) were analyzed.

Main Results:

  • CD3/CD28 stimulation activated both ERK and IL-2/STAT5 signaling pathways.
  • PMA/ionomycin predominantly induced ERK-dependent proliferation, despite robust IL-2 production and CD25 upregulation.
  • Distinct signaling profiles were observed between the two activation methods.

Conclusions:

  • Pharmacological and receptor-mediated T-cell activation induce fundamentally different signaling programs.
  • Methodological choices significantly impact observed T-cell activation outcomes.
  • These findings highlight mechanistic differences critical for interpreting T-cell activation studies.